4.4 Review

Geroprotective interventions in the 3xTg mouse model of Alzheimer's disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analyses

Susana Lopez-Ortiz et al.

Summary: The study summarizes the relationship between physical activity and the development of Alzheimer's disease, as well as the impact of exercise on patients with Alzheimer's disease. The findings suggest that physical activity can lower the risk of Alzheimer's disease and exercise has positive effects on cognitive function, physical performance, and functional independence.

JOURNAL OF NEUROLOGY (2023)

Article Cell Biology

Sex and genetic background define the metabolic, physiologic, and molecular response to protein restriction

Cara L. Green et al.

Summary: Research has found that the improvement of metabolic health through reduced dietary protein strongly depends on sex and strain. While some phenotypes remain consistent across different strains and sexes, there is high variability in adiposity, insulin sensitivity, and circulating hormones.

CELL METABOLISM (2022)

Article Neurosciences

JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model

Jessica L. Dennison et al.

Summary: JOTROL, a novel oral formulation of resveratrol, has higher bioavailability compared to non-formulated resveratrol. It has been found to be effective in the prevention and treatment of AD by regulating AD-related gene expression, inhibiting inflammatory genes, and regulating cytokine levels.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Article Neurosciences

Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer's Disease

Steven G. Fagan et al.

Summary: This study demonstrates that fingolimod may be a potential multimodal therapeutic for Alzheimer's disease, as it can reverse deficits in spatial working memory, alleviate inflammation in the brain, and reduce tau and APP levels in key brain regions.

MOLECULAR NEUROBIOLOGY (2022)

Article Neurosciences

The effect of exercise on early sensorimotor performance alterations in the 3xTg-AD model of Alzheimer's disease

Sonja K. Bareiss et al.

Summary: Alzheimer's disease is associated with a decline in cognitive function as well as non-cognitive sensorimotor and psychomotor symptoms. While exercise is believed to be beneficial for AD, its effect on sensorimotor functions is not well understood. In this study, researchers found that exercise can improve sensorimotor function and reduce abnormal behavior in a mouse model of AD.

NEUROSCIENCE RESEARCH (2022)

Article Cell Biology

Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer's Disease

Sudhir Kshirsagar et al.

Summary: The purpose of this study is to investigate the early cellular, molecular, morphological, and behavioral changes in humanized amyloid-beta-knock-in (hAbKI) mice. The findings suggest that amyloid-beta is sufficient to cause behavioral, mitochondrial, synaptic, and ultrastructural changes in mice.
Review Cell Biology

The central moTOR of metabolism

Judith Simcox et al.

Summary: This review discusses the importance of protein kinase mechanistic target of rapamycin (mTOR) in metabolic regulation, its role in regulating the metabolism of the four macromolecular building blocks of the cell, and its impact on organismal physiology and aging. It also explores the potential clinical application of mTOR inhibitors in the treatment and prevention of age-related diseases.

DEVELOPMENTAL CELL (2022)

Article Geriatrics & Gerontology

Differential effects of calorie restriction and rapamycin on age-related molecular and functional changes in skeletal muscle

Melissa C. Orenduff et al.

Summary: Aging is a complex process that involves the progressive deterioration of physiological integrity and function. Loss of muscle mass, strength, and function, known as sarcopenia, is one of the major contributors to the harmful effects of aging. Calorie restriction (CR) has been shown to extend lifespan and delay the onset and progression of age-related diseases, including sarcopenia. Rapamycin, a pharmacological compound, has demonstrated similar longevity benefits without the need for dietary restrictions. In our study, we found that both CR and rapamycin can partially protect against age-related muscle decline, but they engage different molecular pathways in skeletal muscle. The therapeutic potential of rapamycin or a CR regimen in preventing and managing sarcopenia should be further explored in translational studies.

EXPERIMENTAL GERONTOLOGY (2022)

Review Biochemistry & Molecular Biology

Antidiabetic Drugs in the Treatment of Alzheimer's Disease

Michalis Michailidis et al.

Summary: The public health burden of type 2 diabetes mellitus and Alzheimer's disease is increasing, especially in older adults. Recent studies have found that certain antidiabetic medications can improve cognition and memory in patients with Alzheimer's disease. This review examines the latest evidence for the potential use of antidiabetic medications in treating Alzheimer's disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Cell Biology

Molecular mechanisms of dietary restriction promoting health and longevity

Cara L. Green et al.

Summary: Dietary restriction with adequate nutrition is considered the gold standard for delaying ageing and extending healthspan and lifespan in various species, as it impacts key nutrient-sensing signalling pathways to promote healthy longevity.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)

Review Neurosciences

Impaired insulin signalling and allostatic load in Alzheimer disease

Fernanda G. De Felice et al.

Summary: This review discusses the role of impaired insulin signalling and allostatic load in Alzheimer's disease (AD) and highlights the potential of social and lifestyle interventions in preserving brain health and preventing AD.

NATURE REVIEWS NEUROSCIENCE (2022)

Article Multidisciplinary Sciences

Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscle

Daniel J. Ham et al.

Summary: The anti-aging intervention calorie restriction (CR) is thought to act via the nutrient-sensing multiprotein complex mTORC1. However, this study showed that the mTORC1-inhibitor rapamycin and CR use largely distinct mechanisms to slow mouse muscle aging.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

FGF21 is required for protein restriction to extend lifespan and improve metabolic health in male mice

Cristal M. Hill et al.

Summary: Restriction of dietary protein can extend the lifespan and improve metabolic health in mice, and the endocrine hormone FGF21 is essential for the anti-aging effect of this dietary intervention.

NATURE COMMUNICATIONS (2022)

Review Clinical Neurology

Glucose metabolism and AD: evidence for a potential diabetes type 3

Andrea Gonzalez et al.

Summary: This study explores the influence of glucose metabolism on Alzheimer's disease from three different perspectives, including its role as a regulator of energy source, its impact on immune system activation through metabolic abnormalities, and its regulation of post-translational modifications in key proteins. The findings support the hypothesis that AD is a new type of diabetes.

ALZHEIMERS RESEARCH & THERAPY (2022)

Article Endocrinology & Metabolism

Detrimental effects of branched-chain amino acids in glucose tolerance can be attributed to valine induced glucotoxicity in skeletal muscle

Christopher A. Bishop et al.

Summary: This study investigates the roles of branched-chain amino acids (BCAA) in metabolic health and finds that leucine has beneficial effects on adiposity and insulin sensitivity, while valine intake worsens glucose tolerance and insulin sensitivity.

NUTRITION & DIABETES (2022)

Review Neurosciences

Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond

Chenghuan Song et al.

Summary: Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly. The failure of AD drug development is mainly due to discrepancies in understanding the disease mechanism, but ongoing studies provide new avenues for unraveling disease mechanisms and guiding drug development. Immunotherapeutic strategies targeting amyloid-beta (Aβ) and tau proteins were once considered effective, but the repeated failures of clinical trials have raised doubts. However, the recent approval of a new anti-Aβ monoclonal antibody renews hope in immunotherapy strategies targeting Aβ. Other immunotherapeutic strategies targeting tau, microglia, and the gut-brain axis are also under development.

TRANSLATIONAL NEURODEGENERATION (2022)

Article Multidisciplinary Sciences

[11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's disease

Tharick A. Pascoal et al.

Summary: Alzheimer's disease is characterized by the accumulation of amyloid-beta and tau proteins in the brain. Epigenetic dysregulation has been found to play a role in the interaction between these protein abnormalities, neurodegeneration, and cognitive impairment.

NATURE COMMUNICATIONS (2022)

Review Plant Sciences

Regulation of Gene Expression through Food-Curcumin as a Sirtuin Activity Modulator

Anca Ungurianu et al.

Summary: The sirtuin family plays a crucial role in regulating various physiological functions, and can have beneficial effects through modulating their activity. Curcumin and its metabolites are considered effective molecules in regulating sirtuin activity, and have antioxidant, anti-inflammatory, and anticancer properties.

PLANTS-BASEL (2022)

Article Clinical Neurology

Effectiveness of motor-cognitive dual-task exercise via telerehabilitation in Alzheimer's disease: An online pilot randomized controlled study.

Kubra Nur Menengic et al.

Summary: This study investigated the effectiveness of home-based telerehabilitation (TR) in treating Alzheimer's disease (AD). The results showed that TR may significantly improve cognition and mobility, enhance functional independence, and reduce anxiety and depressive symptoms in AD patients.

CLINICAL NEUROLOGY AND NEUROSURGERY (2022)

Article Medicine, General & Internal

Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer's disease: protocol for the ExPlas study

Atefe R. Tari et al.

Summary: This study aims to test the safety and tolerability of transfusing exercised plasma to patients with mild cognitive impairment or early Alzheimer's disease, and examine its effects on cognitive function, fitness level, cerebral blood flow, and biomarkers.

BMJ OPEN (2022)

Article Cell Biology

Fasting-mimicking diet cycles reduce neuroinflammation to attenuate cognitive decline in Alzheimer's models

Priya Rangan et al.

Summary: The research suggests that fasting-mimicking diet cycles can help reduce cognitive decline and Alzheimer's disease pathology, with effects superior to protein restriction cycles. By reducing neuroinflammation and superoxide production, it delays cognitive decline in AD models.

CELL REPORTS (2022)

Review Pharmacology & Pharmacy

Therapeutic insights elaborating the potential of retinoids in Alzheimer's disease

Tapan Behl et al.

Summary: Alzheimer's disease is a complex neurodegenerative disorder characterized by various pathological processes, including disrupted retinoid signaling. Retinoids are involved in the immune function and play critical roles in the normal functioning of the nervous system. Disturbed retinoid signaling can lead to inflammation, oxidative stress, and neurodegeneration, contributing to the progression of Alzheimer's disease.

FRONTIERS IN PHARMACOLOGY (2022)

Article Multidisciplinary Sciences

Rapamycin treatment during development extends life span and health span of male mice and Daphnia magna

Anastasia Shindyapina et al.

Summary: This study found that exposure to rapamycin during development can extend lifespan and reduce body size in mice and water fleas. By slowing down development and aging, rapamycin effectively preserves health and extends lifespan.

SCIENCE ADVANCES (2022)

Review Immunology

Immunotherapies for Alzheimer's Disease-A Review

Zachary Valiukas et al.

Summary: Alzheimer's disease is a chronic neurodegenerative disorder characterized by the presence of toxic substances in the brain. Traditional drug treatments have limitations, leading to the exploration of immunotherapies, which target the production and deposition of these substances.

VACCINES (2022)

Article Biochemistry & Molecular Biology

Nicotinamide riboside ameliorates high-fructose-induced lipid metabolism disorder in mice via improving FGF21 resistance in the liver and white adipose tissue

Hui Zhao et al.

Summary: This study found that NR supplementation can improve high-fructose-induced lipid metabolism disorder by improving FGF21 resistance in the liver and WAT, which may be related to the regulation of inflammation mediated by the SIRT1/NF-kappa B signaling pathway.

FOOD & FUNCTION (2022)

Article Chemistry, Medicinal

Pioglitazone Ameliorates Hippocampal Neurodegeneration, Disturbances in Glucose Metabolism and AKT/mTOR Signaling Pathways in Pentyelenetetrazole-Kindled Mice

Nada El-Megiri et al.

Summary: The present study aimed to investigate the potential neuroprotective effect of Pioglitazone in PTZ kindled seizure in mice. Treatment with Pioglitazone demonstrated a significant decrease in NGF, seizure score, m-TOR, GLUT-1 and GLUT-3 in comparison to the PTZ group, suggesting that Pioglitazone provides its neuroprotective effect through modulating m-TOR signaling, glucose metabolism and NGF levels.

PHARMACEUTICALS (2022)

Article Nutrition & Dietetics

Long-term dietary protein intake and subjective cognitive decline in US men and women

Tian-Shin Yeh et al.

Summary: This study revealed that higher protein intake, especially when compared to carbohydrates, was associated with lower odds of subjective cognitive decline. Plant protein sources were also found to be beneficial in reducing the risk of cognitive decline compared to animal protein sources.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2022)

Article Hospitality, Leisure, Sport & Tourism

Inter-individual differences in the responses to aerobic exercise in Alzheimer's disease: Findings from the FIT-AD trial

Fang Yu et al.

Summary: Inter-individual differences in aerobic fitness and cognitive responses to aerobic exercise were found in older adults with mild-to-moderate dementia due to AD, highlighting the potential impact on treatment outcomes.

JOURNAL OF SPORT AND HEALTH SCIENCE (2021)

Review Cell Biology

Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials

Susana Lopez-Ortiz et al.

Summary: This study systematically evaluated the effects of exercise interventions on patients with Alzheimer's disease in terms of cognitive function, physical function, functional independence, and neuropsychiatric symptoms. The results suggest that exercise interventions can have significant benefits in multiple domains for patients with AD.

AGEING RESEARCH REVIEWS (2021)

Article Neurosciences

Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies

Essi F. Biyong et al.

Summary: Vitamin A is critical for maintaining memory function with advancing age, and impaired brain Vitamin A signaling may contribute to the onset of Alzheimer's disease. A study found that chronic exposure of 3xTg-AD mice to a Vitamin A-enriched diet may be protective in males but not in females.

NEUROBIOLOGY OF DISEASE (2021)

Article Neurosciences

Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial

Fang Yu et al.

Summary: The study found that for older adults with mild-to-moderate Alzheimer's disease, exercise may help reduce the decline in global cognition. However, aerobic exercise did not show superior cognitive effects compared to stretching, possibly due to the lack of power in the pilot trial.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Review Biochemistry & Molecular Biology

The Therapeutic Potential of Carnosine/Anserine Supplementation against Cognitive Decline: A Systematic Review with Meta-Analysis

Giuseppe Caruso et al.

Summary: Carnosine, proposed as an anti-aging agent over 20 years ago, has shown antioxidant, anti-inflammatory, and anti-aggregation activity with neuroprotective effects in animal models of Alzheimer's disease. Global cognitive function was improved after 12 weeks of carnosine/anserine supplementation at a dose of 1 g/day in elderly subjects, while no effects were observed on depressive symptoms.

BIOMEDICINES (2021)

Article Cell Biology

Rhesus monkeys as a translational model for late-onset Alzheimer's disease

Dylan C. Souder et al.

Summary: Age is a major risk factor for late-onset Alzheimer's disease, and differences in the amyloid plaque microenvironment and the impact of AD pathology on local metabolism and inflammation vary among species, potentially explaining differences in neurodegeneration and functional decline. Using brain tissue from transgenic mice, rhesus monkeys, and human subjects, altered energetics in the plaque microenvironment were observed, highlighting the advantage of nonhuman primates in modeling the disease.

AGING CELL (2021)

Article Cell Biology

The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine

Deyang Yu et al.

Summary: The study found that different branched-chain amino acids (BCAAs) have distinct metabolic effects, with low isoleucine diet improving hepatic insulin sensitivity and energy expenditure. It is suggested that reducing isoleucine may be a new approach to treating and preventing obesity and diabetes.

CELL METABOLISM (2021)

Article Neurosciences

mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease

Candice E. Van Skike et al.

Summary: The study reveals that in an Alzheimer's disease model, mTOR drives impairments in neurovascular coupling (NVC) through inhibition of neuronal nitric oxide synthase (nNOS) and non-NOS-dependent components. However, attenuation of mTOR activity effectively restores NVC function and can even enhance it above normal responses. This suggests that targeting mTOR may be a potential treatment for Alzheimer's disease and other neurological diseases associated with aging.

JOURNAL OF NEUROSCIENCE (2021)

Article Multidisciplinary Sciences

Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer's disease-like pathology

David Baglietto-Vargas et al.

Summary: The researchers created a mouse model that expresses wildtype human A β, demonstrating effects on cognition, synaptic plasticity, brain changes, inflammation, PAS granules, and gene expression. Furthermore, excision of exon 14 through Cre-mediated methods reduced A β expression and rescued cognitive impairments.

NATURE COMMUNICATIONS (2021)

Review Clinical Neurology

Anticancer drugs repurposed for Alzheimer's disease: a systematic review

Antonio Ancidoni et al.

Summary: The relationship between cancer and dementia has sparked interest in repurposing anticancer agents for Alzheimer's disease. Clinical trials testing approved anticancer drugs in AD show promise, but published studies on the topic have controversial findings. Larger and high-quality clinical trials are needed to confirm and extend the promising results from preclinical studies.

ALZHEIMERS RESEARCH & THERAPY (2021)

Review Neurosciences

A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease

Natalia Kyrtata et al.

Summary: Alzheimer's disease is associated with alterations in glucose transporters, possibly leading to reduced glucose transport across the blood-brain barrier and cell membranes, resulting in glucose deprivation and accelerated cognitive decline. Studies suggest that anti-diabetic medications show promise in improving glucose transport capacity in AD patients.

FRONTIERS IN NEUROSCIENCE (2021)

Article Neurosciences

A current view on Tau protein phosphorylation in Alzheimer's disease

Susanne Wegmann et al.

Summary: The functions of Tau in the central nervous system are regulated by various posttranslational modifications, with phosphorylation being widely recognized as a pathological hallmark in diseases like AD. However, the similarities and heterogeneity of phosphorylation patterns between physiological and pathological Tau make it challenging to identify specific modifications as therapeutic targets and biomarkers.

CURRENT OPINION IN NEUROBIOLOGY (2021)

Article Neurosciences

Intranasal Paclitaxel Alters Alzheimer's Disease Phenotypic Features in 3xTg-AD Mice

Donna J. Cross et al.

Summary: Intranasally administered microtubule-stabilizing drugs, specifically paclitaxel, have shown promise in altering the phenotypic progression of Alzheimer's disease in 3xTg-AD mice. These drugs can increase axonal transport rates, reduce phospho-tau containing neurons, improve performance in behavioral tests, and decrease anxiety-related behaviors.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Review Biochemistry & Molecular Biology

The Amyloid-β Pathway in Alzheimer's Disease

Harald Hampel et al.

Summary: Breakthroughs in molecular medicine have highlighted the significance of the amyloid-beta pathway in the pathophysiology of Alzheimer's disease. Established biochemical alterations of the A beta cycle serve as promising targets for the development of disease-modifying therapies. Research indicates a crucial role of A beta pathway dyshomeostasis in the dynamics of AD pathophysiology, supporting the development of A beta-targeting therapeutic strategies for early treatment of AD.

MOLECULAR PSYCHIATRY (2021)

Article Behavioral Sciences

Marked Mild Cognitive Deficits in Humanized Mouse Model of Alzheimer's-Type Tau Pathology

Joshua D. Cho et al.

Summary: While aged htau mice show a significant short-term spatial memory deficit, no major impairments in long-term learning and memory were found. Discrepancies in reported cognitive deficits within the literature may be attributed to differences in task difficulty and procedural details, highlighting the necessity for thorough characterization of behavioral deficits in AD mouse models before evaluating treatment efficacy.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2021)

Review Neurosciences

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms

Zenghui Wei et al.

Summary: Alzheimer's disease is a chronic neurodegenerative disease that accounts for a majority of dementia cases and is one of the leading causes of death in the United States. Insulin resistance has been shown to play a significant role in the development of AD, with over 80% of patients also having type II diabetes, suggesting overlapping pathogenic mechanisms. Insulin resistance increases neuroinflammation, leading to amyloid beta-protein deposition and aberrant tau phosphorylation, ultimately contributing to the progression of AD.

FRONTIERS IN NEUROSCIENCE (2021)

Review Biochemistry & Molecular Biology

Carnosine, Small but Mighty-Prospect of Use as Functional Ingredient for Functional Food Formulation

Ivana Jukic et al.

Summary: Carnosine is a dipeptide synthesized in the body with beneficial antioxidant properties, mainly found in the brain, muscle, and gastrointestinal tissues. Its component beta-alanine can serve as a dietary supplement to increase muscle carnosine and improve exercise effectiveness. While widely used among athletes, carnosine is less commonly utilized in cardiovascular or diabetic patients.

ANTIOXIDANTS (2021)

Article Endocrinology & Metabolism

Fasting drives the metabolic, molecular and geroprotective effects of a calorie-restricted diet in mice

Heidi H. Pak et al.

Summary: The study demonstrates that prolonged fasting plays a crucial role in the effects of calorie restriction on insulin sensitivity, fuel utilization, and aging in mice. Simply reducing caloric intake alone is not enough to replicate all these effects, highlighting the importance of daily prolonged fasting in regulating metabolic health and longevity.

NATURE METABOLISM (2021)

Article Geriatrics & Gerontology

Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer's disease in comparison with healthy aging

Maria Conte et al.

Summary: FGF21, GDF15, and HN are mitokines related to mitochondrial stress and positively correlated with age, showing different expressions in type 2 diabetes and Alzheimer's disease, suggesting FGF21 as a candidate marker of healthy aging.

GEROSCIENCE (2021)

Article Geriatrics & Gerontology

Next Generation Strategies for Geroprotection via mTORC1 Inhibition

Sabrina N. Dumas et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)

Review Pharmacology & Pharmacy

Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation

Surabhi Shukla et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Biochemistry & Molecular Biology

Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities

Lei Meng et al.

TRENDS IN MOLECULAR MEDICINE (2020)

Article Biochemistry & Molecular Biology

Neuroprotective Effects of Chronic Resveratrol Treatment and Exercise Training in the 3xTg-AD Mouse Model of Alzheimer's Disease

Tom L. Broderick et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice

Alejandro R. Roda et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, Research & Experimental

Canagliflozin extends life span in genetically heterogeneous male but not female mice

Richard A. Miller et al.

JCI INSIGHT (2020)

Article Clinical Neurology

Results from a pilot study: The effects of nicotinamide riboside on mild cognitive impairment

Miranda E. Orr et al.

Alzheimers & Dementia (2020)

Article Cell Biology

Rapamycin and Alzheimer's disease: Time for a clinical trial?

Matt Kaeberlein et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Editorial Material Cell Biology

Rapamycin and Alzheimer disease: a double-edged sword?

Julian M. Carosi et al.

AUTOPHAGY (2019)

Article Endocrinology & Metabolism

Repeated cold exposures protect a mouse model of Alzheimer's disease against cold-induced tau phosphorylation

Marine Tournissac et al.

MOLECULAR METABOLISM (2019)

Review Neurosciences

Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential

Efthalia Angelopoulou et al.

NEUROMOLECULAR MEDICINE (2019)

Article Multidisciplinary Sciences

A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals

Joris Deelen et al.

NATURE COMMUNICATIONS (2019)

Article Nutrition & Dietetics

Of Older Mice and Men: Branched-Chain Amino Acids and Body Composition

Rosilene Ribeiro et al.

NUTRIENTS (2019)

Article Cell Biology

Acarbose improves health and lifespan in aging HET3 mice

David E. Harrison et al.

AGING CELL (2019)

Article Clinical Neurology

2019 Alzheimer's disease facts and figures

Joseph Gaugler et al.

ALZHEIMERS & DEMENTIA (2019)

Article Endocrinology & Metabolism

Branched-chain amino acids impact health and lifespan indirectly via amino acid balance and appetite control

Samantha M. Solon-Biet et al.

NATURE METABOLISM (2019)

Article Neurosciences

Restoration of metabolic health by decreased consumption of branched-chain amino acids

Nicole E. Cummings et al.

JOURNAL OF PHYSIOLOGY-LONDON (2018)

Article Cardiac & Cardiovascular Systems

Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment

Candice E. Van Skike et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)

Article Medicine, Research & Experimental

FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats

Piangkwan Sa-nguanmoo et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Endocrinology & Metabolism

Homeostatic sensing of dietary protein restriction: A case for FGF21

Cristal M. Hill et al.

FRONTIERS IN NEUROENDOCRINOLOGY (2018)

Article Geriatrics & Gerontology

Executive function: Responses to aerobic exercise in Alzheimer's disease

Fang Yu et al.

GERIATRIC NURSING (2018)

Article Neurosciences

Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-beta

W. M. A. D. Binosha Fernando et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Review Cell Biology

Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease

Min Chen et al.

NEURAL REGENERATION RESEARCH (2018)

Article Multidisciplinary Sciences

NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency

Yujun Hou et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

Inhibition of HDAC3 reverses Alzheimer's disease-related pathologies in vitro and in the 3xTg-AD mouse model

Karolina J. Janczura et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Neurosciences

Insulin Resistance in Alzheimer's Disease

Lais S. S. Ferreira et al.

FRONTIERS IN NEUROSCIENCE (2018)

Article Sport Sciences

Exercise Attenuates High-Fat Diet-induced Disease Progression in 3xTg-AD Mice

Donghyun Kim et al.

MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2017)

Article Geriatrics & Gerontology

Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease

Ramon Velazquez et al.

NEUROBIOLOGY OF AGING (2017)

Review Neurosciences

Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms

Jesse S. Kerr et al.

TRENDS IN NEUROSCIENCES (2017)

Review Clinical Neurology

On the path to 2025: understanding the Alzheimer's disease continuum

Paul S. Aisen et al.

ALZHEIMERS RESEARCH & THERAPY (2017)

Review Neurosciences

Atypical, non-standard functions of the microtubule associated Tau protein

Ioannis Sotiropoulos et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)

Article Neurosciences

Alzheimer's Disease and the Amyloid-β Peptide

M. Paul Murphy et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Multidisciplinary Sciences

Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial

Jill K. Morris et al.

PLOS ONE (2017)

Article Multidisciplinary Sciences

Low protein-induced increases in FGF21 drive UCP1-dependent metabolic but not thermoregulatory endpoints

Cristal M. Hill et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice

Hameetha Rajamohamedsait et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

Branched-chain amino acids and Alzheimer's disease: a Mendelian randomization analysis

Susanna C. Larsson et al.

SCIENTIFIC REPORTS (2017)

Review Multidisciplinary Sciences

Resveratrol for Alzheimer's disease

Christine Sawda et al.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)

Article Cell Biology

FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms

Lucas BonDurant et al.

CELL METABOLISM (2017)

Review Chemistry, Medicinal

Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors

Eunah Kim et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)

Review Cell Biology

The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging

Brian K. Kennedy et al.

CELL METABOLISM (2016)

Editorial Material Biochemistry & Molecular Biology

Glucose Metabolism: A Sweet Relief of Alzheimer's Disease

Claudia Duran-Aniotz et al.

CURRENT BIOLOGY (2016)

Review Biochemistry & Molecular Biology

Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation

Niek G. J. Leus et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2016)

Article Pharmacology & Pharmacy

Treatment of Alzheimer Disease With CT Scans: A Case Report

Jerry M. Cuttler et al.

DOSE-RESPONSE (2016)

Article Public, Environmental & Occupational Health

Cumulative consumption of branched-chain amino acids and incidence of type 2 diabetes

Yan Zheng et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)

Review Medicine, Research & Experimental

Sphingosine 1-phosphate in metabolic syndrome

Wei Chen et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)

Letter Geriatrics & Gerontology

Evaluation of a Community-Based Exercise Program for Managing Alzheimer's Disease

Jennifer J. Heisz et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)

Article Geriatrics & Gerontology

Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice

Sebastian I. Arriola Apelo et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2016)

Review Biochemistry & Molecular Biology

Caloric restriction: beneficial effects on brain aging and Alzheimer's disease

Caroline Van Cauwenberghe et al.

MAMMALIAN GENOME (2016)

Review Geriatrics & Gerontology

Carnosine and the processes of ageing

Alan R. Hipkiss et al.

MATURITAS (2016)

Article Biochemistry & Molecular Biology

A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance

Cholsoon Jang et al.

NATURE MEDICINE (2016)

Review Cell Biology

Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds

Michael S. Bonkowski et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)

Review Cell Biology

Resveratrol supplementation: Where are we now and where should we go?

Marta G. Novelle et al.

AGEING RESEARCH REVIEWS (2015)

Article Behavioral Sciences

Analysis of motor function in 6-month-old male and female 3xTg-AD mice

Kurt R. Stover et al.

BEHAVIOURAL BRAIN RESEARCH (2015)

Article Behavioral Sciences

Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease

Kurt R. Stover et al.

BEHAVIOURAL BRAIN RESEARCH (2015)

Article Biochemistry & Molecular Biology

Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease

Milene Vandal et al.

FASEB JOURNAL (2015)

Article Medicine, Research & Experimental

Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity

Shihyin Tsai et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Geriatrics & Gerontology

Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice

Marissa J. Schafer et al.

NEUROBIOLOGY OF AGING (2015)

Review Cell Biology

An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol

Ashim Malhotra et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)

Editorial Material Genetics & Heredity

The age factor in Alzheimer's disease

Rita Guerreiro et al.

GENOME MEDICINE (2015)

Article Geriatrics & Gerontology

Rapamycin and Dietary Restriction Induce Metabolically Distinctive Changes in Mouse Liver

Zhen Yu et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2015)

Article Biochemistry & Molecular Biology

A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents

Brian Finan et al.

NATURE MEDICINE (2015)

Article Gerontology

Impact of 6-Month Aerobic Exercise on Alzheimer's Symptoms

Fang Yu et al.

JOURNAL OF APPLIED GERONTOLOGY (2015)

Review Clinical Neurology

Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis

Sofia Lopes da Silva et al.

ALZHEIMERS & DEMENTIA (2014)

Article Biochemistry & Molecular Biology

Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain

Marzia Perluigi et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Article Pharmacology & Pharmacy

Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice

Chen Wang et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2014)

Review Biochemistry & Molecular Biology

Caloric restriction and the aging process: a critique

Rajindar S. Sohal et al.

FREE RADICAL BIOLOGY AND MEDICINE (2014)

Article Neurosciences

Acute Aerobic Exercise Increases Brain-Derived Neurotrophic Factor Levels in Elderly with Alzheimer's Disease

Flavia Gomes de Melo Coelho et al.

JOURNAL OF ALZHEIMERS DISEASE (2014)

Article Medicine, Research & Experimental

FGF21 is an endocrine signal of protein restriction

Thomas Laeger et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Review Biochemistry & Molecular Biology

The rhythm of retinoids in the brain

Jemma Ransom et al.

JOURNAL OF NEUROCHEMISTRY (2014)

Article Immunology

IVIg protects the 3xTg-AD mouse model of Alzheimer's disease from memory deficit and Aβ pathology

Isabelle St-Amour et al.

JOURNAL OF NEUROINFLAMMATION (2014)

Article Geriatrics & Gerontology

Advances in Geroscience: Impact on Healthspan and Chronic Disease

John B. Burch et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)

Article Neurosciences

p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice

Ken C. Walls et al.

NEUROSCIENCE LETTERS (2014)

Article Cell Biology

Erasers of Histone Acetylation: The Histone Deacetylase Enzymes

Edward Seto et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)

Article Multidisciplinary Sciences

Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys

Ricki J. Colman et al.

NATURE COMMUNICATIONS (2014)

Review Neurosciences

Effects of Diet on Brain Plasticity in Animal and Human Studies: Mind the Gap

Tytus Murphy et al.

NEURAL PLASTICITY (2014)

Article Neurosciences

Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis

Timothy A. Couttas et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)

Review Rehabilitation

Systematic Review of the Effects of Exercise on Activities of Daily Living in People With Alzheimer's Disease

Ashwini K. Rao et al.

AMERICAN JOURNAL OF OCCUPATIONAL THERAPY (2014)

Article Neurosciences

Characterization of Mitochondrial Dysfunction in the 7PA2 Cell Model of Alzheimer's Disease

Nina Krako et al.

JOURNAL OF ALZHEIMERS DISEASE (2013)

Article Geriatrics & Gerontology

Short-Term Treatment With Rapamycin and Dietary Restriction Have Overlapping and Distinctive Effects in Young Mice

Wilson C. Fok et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)

Article Multidisciplinary Sciences

Metformin improves healthspan and lifespan in mice

Alejandro Martin-Montalvo et al.

NATURE COMMUNICATIONS (2013)

Article Medicine, General & Internal

Effects of the Finnish Alzheimer Disease Exercise Trial (FINALEX) A Randomized Controlled Trial

Kaisu H. Pitkala et al.

JAMA INTERNAL MEDICINE (2013)

Article Cell Biology

Rapamycin slows aging in mice

John E. Wilkinson et al.

AGING CELL (2012)

Review Biochemistry & Molecular Biology

Retinoids for treatment of Alzheimer's disease

Alan J. Lerner et al.

BIOFACTORS (2012)

Article Cell Biology

TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO

Stacey Robida-Stubbs et al.

CELL METABOLISM (2012)

Review Pharmacology & Pharmacy

Transgenic Mouse Models of Alzheimer Disease: Developing a Better Model as a Tool for Therapeutic Interventions

Masashi Kitazawa et al.

CURRENT PHARMACEUTICAL DESIGN (2012)

Article Neurosciences

Relative Intake of Macronutrients Impacts Risk of Mild Cognitive Impairment or Dementia

Rosebud O. Roberts et al.

JOURNAL OF ALZHEIMERS DISEASE (2012)

Article Medicine, General & Internal

Computer Activities, Physical Exercise, Aging, and Mild Cognitive Impairment: A Population-Based Study

Yonas E. Geda et al.

MAYO CLINIC PROCEEDINGS (2012)

Article Geriatrics & Gerontology

Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse

Yoelvis Garcia-Mesa et al.

NEUROBIOLOGY OF AGING (2012)

Article Multidisciplinary Sciences

Role of genes linked to sporadic Alzheimer's disease risk in the production of β-amyloid peptides

Jitin Bali et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Neurosciences

Influence of isotretinoin on hippocampal-based learning in human subjects

Anthony D. Ormerod et al.

PSYCHOPHARMACOLOGY (2012)

Article Multidisciplinary Sciences

Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity

Dudley W. Lamming et al.

SCIENCE (2012)

Review Neurosciences

A vitamin for the brain

Kirsty D. Shearer et al.

TRENDS IN NEUROSCIENCES (2012)

Review Cell Biology

Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?

Sonia C. Correia et al.

AGEING RESEARCH REVIEWS (2011)

Review Cardiac & Cardiovascular Systems

Caloric restriction: powerful protection for the aging heart and vasculature

Edward P. Weiss et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)

Review Biochemistry & Molecular Biology

Caloric Restriction in Humans: Impact on Physiological, Psychological, and Behavioral Outcomes

Leanne M. Redman et al.

ANTIOXIDANTS & REDOX SIGNALING (2011)

Article Geriatrics & Gerontology

Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice

Richard A. Miller et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)

Review Cell Biology

Targeting HDACs: A Promising Therapy for Alzheimer's Disease

Ke Xu et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2011)

Review Clinical Neurology

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

Randall J. Bateman et al.

ALZHEIMERS RESEARCH & THERAPY (2011)

Article Pathology

Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice

Vladimir N. Anisimov et al.

AMERICAN JOURNAL OF PATHOLOGY (2010)

Article Biochemistry & Molecular Biology

Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration

Sebastien S. Hebert et al.

HUMAN MOLECULAR GENETICS (2010)

Article Biochemistry & Molecular Biology

Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau EFFECTS ON COGNITIVE IMPAIRMENTS

Antonella Caccamo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Review Food Science & Technology

Significance of vitamin A to brain function, behavior and learning

Christopher R. Olson et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2010)

Review Neurosciences

Autophagy gone awry in neurodegenerative diseases

Esther Wong et al.

NATURE NEUROSCIENCE (2010)

Review Medicine, General & Internal

MECHANISMS OF DISEASE Alzheimer's Disease

Henry W. Querfurth et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Multidisciplinary Sciences

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

David E. Harrison et al.

NATURE (2009)

Review Neurosciences

Zinc in the physiology and pathology of the CNS

Stefano L. Sensi et al.

NATURE REVIEWS NEUROSCIENCE (2009)

Article Neurosciences

Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice

Peter R. Mouton et al.

NEUROSCIENCE LETTERS (2009)

Article Multidisciplinary Sciences

Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

Jia Yao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Caloric restriction improves memory in elderly humans

A. V. Witte et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice

Virginie Rhein et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span

Colin Selman et al.

SCIENCE (2009)

Article Biochemistry & Molecular Biology

mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells

Chong Chen et al.

SCIENCE SIGNALING (2009)

Article Immunology

Natural human antibodies to amyloid beta peptide

Paul Szabo et al.

AUTOIMMUNITY REVIEWS (2008)

Article Pharmacology & Pharmacy

Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease

Aynun N. Begum et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Article Multidisciplinary Sciences

Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression

Sebastien S. Hebert et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Multidisciplinary Sciences

Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration

Trinna L. Cuellar et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

The fasting polypeptide FGF21 can enter brain from blood

Hung Hsuchou et al.

PEPTIDES (2007)

Article Medicine, General & Internal

A Randomized trial of beta carotene supplementation and cognitive function in men - The physicians' health study II

Francine Grodstein et al.

ARCHIVES OF INTERNAL MEDICINE (2007)

Article Multidisciplinary Sciences

Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance

Frederic Tremblay et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

Zinc irreversibly damages major enzymes of energy production and antioxidant Defense prior to mitochondrial permeability transition

Irina G. Gazaryan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Multidisciplinary Sciences

Recovery of learning and memory is associated with chromatin remodelling

Andre Fischer et al.

NATURE (2007)

Article Multidisciplinary Sciences

eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans

Popi Syntichaki et al.

NATURE (2007)

Review Clinical Neurology

Autophagy and neurodegeneration: when the cleaning crew goes on strike

Marta Martinez-Vicente et al.

LANCET NEUROLOGY (2007)

Review Neurosciences

Physiological roles for amyloid β peptides

Hugh A. Pearson et al.

JOURNAL OF PHYSIOLOGY-LONDON (2006)

Article Multidisciplinary Sciences

An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice

Sylvie Le Corre et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Geriatrics & Gerontology

daf-16 protects the nematode Caenorhabditis elegans during food deprivation

Samuel T. Henderson et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)

Review Biotechnology & Applied Microbiology

Therapeutic potential of resveratrol: the in vivo evidence

Joseph A. Baur et al.

NATURE REVIEWS DRUG DISCOVERY (2006)

Article Multidisciplinary Sciences

Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients

M Kaeberlein et al.

SCIENCE (2005)

Article Multidisciplinary Sciences

Tau suppression in a neurodegenerative mouse model improves memory function

K SantaCruz et al.

SCIENCE (2005)

Article Geriatrics & Gerontology

Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models

NV Patel et al.

NEUROBIOLOGY OF AGING (2005)

Article Biochemistry & Molecular Biology

Calories do not explain extension of life span by dietary restriction in Drosophila

W Mair et al.

PLOS BIOLOGY (2005)

Review Neurosciences

Role of retinoid signalling in the adult brain

MA Lane et al.

PROGRESS IN NEUROBIOLOGY (2005)

Article Biochemistry & Molecular Biology

Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo

FS Yang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Cholinergic modulation of microglial activation by α7 nicotinic receptors

RD Shytle et al.

JOURNAL OF NEUROCHEMISTRY (2004)

Article Clinical Neurology

Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer's disease

RC Dodel et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)

Article Neurosciences

Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity

G Gardian et al.

NEUROMOLECULAR MEDICINE (2004)

Article Biochemistry & Molecular Biology

Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway

P Kapahi et al.

CURRENT BIOLOGY (2004)

Review Clinical Neurology

Retinoic acid signaling in the nervous system of adult vertebrates

J Mey et al.

NEUROSCIENTIST (2004)

Article Biochemistry & Molecular Biology

Fast kinetics of taxol binding to microtubules -: Effects of solution variables and microtubule-associated proteins

JF Díaz et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Clinical Neurology

Will caloric restriction and folate protect against AD and PD?

MP Mattson

NEUROLOGY (2003)

Article Geriatrics & Gerontology

Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease

P Rinaldi et al.

NEUROBIOLOGY OF AGING (2003)

Article Agriculture, Multidisciplinary

Plant foods and herbal sources of resveratrol

J Burns et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)

Article Clinical Neurology

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

K Rockwood et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)

Review Medicine, General & Internal

Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus -: A meta-analysis of controlled clinical trials

NG Boulé et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)

Article Biochemistry & Molecular Biology

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

T Nishimura et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2000)